Epigenetics Market Size, Share | Forecast Report 2017 to 2025

    Epigenetics Market Forecast to 2025 – COVID-19 Impact and Global Analysis – by Product (Reagents, Kits, Enzymes, Instruments & Consumables, and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation, and Others), Application (Oncology, Cardiovascular Diseases, and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization)         

    Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 159 | Category: Healthcare IT | Status: Published

    The epigenetics market is projected to reach US$ 2,611.57 million by 2025 from US$ 991.45 million in 2017; it is expected to grow at a CAGR of 13.6% from 2017 to 2025.


    The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes. The changes occurred due to the epigenetic are regular and naturally occurring however, they can also be influenced by several factors such as age, environment, lifestyle, and conditions of diseases. The modifications caused due to the epigenetic can noticeable commonly in the same manner in which cells critically differentiate to end up as skin cells, liver cells, brain cells and others. The epigenetic changes can also be resulted into diseases like cancer.

    The epigenetics market is segmented on the bases of product, technology, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.

    Lucrative Regions for Epigenetics Market

    Lucrative Regions for Epigenetics Market

    Get more information on this report :


    Market Insights

    Declining Prices of Sequencing Drives Epigenetics Market Growth

    The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years. This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP).

    In the recent years, epigenetics price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

    Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market.

    Increasing Prevalence of Cancer Contributes Significantly to Market Growth

    The study of epigenetic alterations in cancer, such as aberrant methylation and altered transcription factor binding, provide insights into tumorigenic pathways, which is located above the genetic code. The microarray and next-generation sequencing (NGS) technologies help to detect altered methylation patterns and other epigenetic changes in cancer. For this, Illumina works with the cancer epigenetics experts to ensure its array and NGS solutions to meet the rapidly growing needs of the field.

    In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Changes in lifestyle has resulted in more exposure to oncogenic factors. For instance, the American Cancer Society estimated 1,658,370 cancer cases to be detected in the US in 2015. Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, epigenetics also aids in research, diagnostics and treatment of cancer.

    Thus, the increase in number of cancer cases are expected to be a prime factor driving the demand for epigenetics market in the coming years.

    Products Insights

    Based on products, the epigenetics market is segmented into reagents, kits, enzymes, instruments & consumables and bioinformatics tools. In 2017, the kits segment held the largest share of the market and is expected to grow at the highest CAGR during 2017–2025. The epigenetic kits allows researchers to perform experiments, researchers to analyze epigenetic modifications efficiently and reliably by using antibodies directed against epitope tags or RNA-binding proteins. In the epigenetics, highly efficient and fast processing kits are developed to perform the experiments. So, the novel toolkits are developed by various companies. The quality control kits are efficient and fast for the preparation of the epigenetic procedures which is the reason for the growth of the segment in epigenetics market.

    Technology Insights

    Based on technology, the epigenetics market is segmented into histone modification, DNA methylation and other technologies. The DNA methylation segment held the largest market share in 2017, and it is further expected to be the largest shareholder in the market by 2025. DNA methylation supports the development of therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects and also helps to prevent conditions that develop during embryonic development such as, abnormal methylation of the X-chromosome and gene imprinting. Thus, owing to the increasing development for therapies for the several diseases in the market are likely to propel the growth of the epigenetics market by technology in the forecast period.

    Application Insights

    Based on application, the global epigenetics market is segmented into metabolic diseases, oncology, cardiovascular diseases and other. In 2017, the oncology segment held the largest share of the market and it is expected to grow at the highest CAGR during 2017–2025. The use of next-generation sequencing (NGS) technology in the diagnostic genome care needs precision and accuracy. Epigenetic modification plays an important role in the development of adult and pediatric cancer. The rate of the cancer is considerably increasing worldwide. The altered methylation often activates or suppress the genes that result in changed epigenome that may affect the gene expression and increase the rate of cancer progression. By sequencing the methylated genome, the methylation analysis with NGS allows the researchers to track and identify the cancer methylation patterns. Thus, owing to the above development for therapies for cancer in the market are likely to propel the growth of the epigenetics market by application in the forecast period.

    End User Insights

    Based on end user, the global epigenetics market is segmented into academic & research institutes, contract research organizations and pharmaceutical & biotechnology companies. In 2017, the pharmaceutical & biotechnology companies segment held the largest share of the market and it is further expected to be the largest shareholder in the market by 2025. The rise in the market for the biotechnological products and various related market has resulted into the enormous market consolidations in between biotechnology and pharmaceutical companies for the enhanced and better treatment options. The growing investments made by companies have grown the pharmaceutical & biotechnology companies segment in the market. The technological development in the molecular biology increased the sequencing procedures. Among the market leaders the companies have manufactured and designed technologically advanced epigenetics technology in last few years. The various collaborations, investments made by the companies and the technological advancements have grown the pharmaceutical & biotechnology companies segment in epigenetics market.

    Epigenetics Market, by Product – 2017 and 2025

    Epigenetics Market, by Product – 2017 and 2025

    Get more information on this report :


    Strategic Insights

    Product launches, and mergers and acquisitions are the highly adopted strategies by the players operating in the global epigenetics market. A few of the recent key product developments are listed below:

    In September 2018, Bio-Rad Laboratories, Inc. launched of its scATAC-Seq solution, a single-cell assay for transposase-accessible chromatin using sequencing. The epigenomics solution enables genome-wide open chromatin sequencing at single-cell resolution.

    In June 2018, Thermo Fisher Scientific Inc., launched of its new Invitrogen TaqMan & SYBR Green Fast Advanced Cells-to-CT Kits, further strengthening its line of RNA Cells-to-CT products. With the Fast Advanced Cells-to-CT Kits, researchers will experience a faster reverse transcriptase reaction and have access to a qPCR master mix system fully optimized to improve sensitivity to detect rare transcripts.

    Epigenetics – Market Segmentation

    By Products

    • Reagents
    • Kits
    • Enzymes
    • Instruments & Consumables
    • Bioinformatics Tools

    By Technology

    • Histone Modification
    • DNA Methylation
    • Others

    By Application

    • Metabolic Diseases
    • Oncology
    • Cardiovascular Diseases
    • Others

    By End User

    • Academics & Research Institutes
    • Contract Research Organizations
    • Biotechnology & Pharmaceutical Companies

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Middle East & Africa (MEA)
      • Saudi Arabia
      • South Africa
      • UAE
      • Rest of Middle East & Africa
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • ABCAM Plc
    • Agilent Technologies
    • Active Motif
    • Qiagen
    • Bio-Rad Laboratories, Inc.
    • Perkinelmer Inc.
    • New England Biolabs (NEB)
    • Illumina Inc.
    TABLE OF CONTENTS

    1. INTRODUCTION 22
    1.1 SCOPE OF THE STUDY 22
    1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 22

    2. GLOBAL EPIGENETICS MARKET - KEY TAKEAWAYS 24

    3. GLOBAL EPIGENETICS MARKET - MARKET LANDSCAPE 27
    3.1 OVERVIEW 27
    3.2 MARKET SEGMENTATION 27
    3.2.1 Global Epigenetics Market - By Product 28
    3.2.2 Global Epigenetics Market - By Technology 28
    3.2.3 Global Epigenetics Market - By Application 29
    3.2.4 Global Epigenetics Market - By End User 29
    3.2.5 Global Epigenetics Market - By Geography 29

    4. GLOBAL EPIGENETICS MARKET - KEY MARKET DYNAMICS 30
    4.1 KEY MARKET DRIVERS 30
    4.1.1 Declining Prices of Sequencing 30
    4.1.2 Increasing Prevalence of Cancer 30
    4.1.3 Funds & Grants Provided By Government Bodies 30
    4.2 KEY MARKET RESTRAINTS 31
    4.2.1 High Cost of Advanced Technologies 31
    4.2.2 Perception of the People For Genetic Alteration 31
    4.3 KEY MARKET OPPORTUNITIES 32
    4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine 32
    4.3.2 Emerging Nations 32
    4.4 KEY MARKET CHALLENGE 33
    4.4.1 Lack of Skilled Professionals 33
    4.5 FUTURE TRENDS 33
    4.5.1 Promising Precise Treatments by Neurogenetics 33
    4.6 IMPACT ANALYSIS 34

    5. EPIGENETICS MARKET - GLOBAL ANALYSIS 35
    5.1 GLOBAL EPIGENETICS MARKET REVENUE FORECASTS AND ANALYSIS 35
    5.2 GLOBAL EPIGENETICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 36
    5.3 MARKET POSITIONING 37
    5.4 PERFORMANCE OF KEY PLAYERS 37
    5.4.1 Thermo Fisher Scientific Inc. 37
    5.4.2 Illumina, Inc. 37
    5.5 EXPERT OPINIONS 38

    6. GLOBAL EPIGENETICS MARKET ANALYSIS - BY PRODUCT 39
    6.1 OVERVIEW 39
    6.2 GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2017 & 2025 (%) 39
    6.3 REAGENTS MARKET 40
    6.3.1 Overview 40
    6.3.2 Global Reagents Market Revenue and Forecasts to 2025 (US$ Mn) 40
    6.4 KITS MARKET 41
    6.4.1 Overview 41
    6.4.2 Global Kits Market Revenue and Forecasts to 2025 (US$ Mn) 41
    6.5 ENZYMES MARKET 42
    6.5.1 Overview 42
    6.5.2 Global Enzymes Market Revenue and Forecasts to 2025 (US$ Mn) 42
    6.6 INSTRUMENTS AND CONSUMABLES MARKET 43
    6.6.1 Overview 43
    6.6.2 Global Instruments and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 44
    6.7 BIOINFORMATICS TOOLS MARKET 45
    6.7.1 Overview 45
    6.7.2 Global Bioinformatics Tools Market Revenue and Forecasts to 2025 (US$ Mn) 45

    7. GLOBAL EPIGENETICS MARKET ANALYSIS - BY TECHNOLOGY 46
    7.1 OVERVIEW 46
    7.2 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%) 46
    7.3 HISTONE MODIFICATION MARKET 47
    7.3.1 Overview 47
    7.3.2 Global Histone Modification Market Revenue and Forecasts to 2025 (US$ Mn) 47
    7.4 DNA METHYLATION MARKET 48
    7.4.1 Overview 48
    7.4.2 Global DNA Methylation Market Revenue and Forecasts to 2025 (US$ Mn) 48
    7.5 OTHER TECHNOLOGIES MARKET 49
    7.5.1 Overview 49
    7.5.2 Global Other Technologies Market Revenue and Forecasts to 2025 (US$ Mn) 49

    8. GLOBAL EPIGENETICS MARKET ANALYSIS - BY APPLICATION 50
    8.1 OVERVIEW 50
    8.2 GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2017 & 2025 (%) 50
    8.3 METABOLIC DISEASES MARKET 51
    8.3.1 Overview 51
    8.3.2 Global Metabolic Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 51
    8.4 ONCOLOGY MARKET 52
    8.4.1 Overview 52
    8.4.2 Global Oncology Market Revenue and Forecasts to 2025 (US$ Mn) 52
    8.5 CARDIOVASCULAR DISEASES MARKET 53
    8.5.1 Overview 53
    8.5.2 Global Cardiovascular Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 54
    8.6 OTHER APPLICATIONS MARKET 55
    8.6.1 Overview 55
    8.6.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 55

    9. GLOBAL EPIGENETICS MARKET ANALYSIS - BY END USER 56
    9.1 OVERVIEW 56
    9.2 GLOBAL EPIGENETICS MARKET, BY END USER, 2017 & 2025 (%) 56
    9.3 ACADEMIC & RESEARCH INSTITUTES MARKET 57
    9.3.1 Overview 57
    9.3.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 57
    9.4 CONTRACT RESEARCH ORGANIZATIONS MARKET 58
    9.4.1 Overview 58
    9.4.2 Global Contract Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn) 58
    9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 59
    9.5.1 Overview 59
    9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn) 59

    10. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 60
    10.1 OVERVIEW 60
    10.2 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
    10.3 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
    10.4 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
    10.5 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
    10.6 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
    10.7 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
    10.8 US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
    10.8.1 US Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 65
    10.8.2 US Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 65
    10.8.3 US Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 66
    10.8.4 US Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
    10.8.5 US Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 66
    10.9 CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
    10.9.1 Canada Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 68
    10.9.2 Canada Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68
    10.9.3 Canada Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 69
    10.9.4 Canada Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 69
    10.9.5 Canada Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 69
    10.10 MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
    10.10.1 Mexico Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 71
    10.10.2 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
    10.10.3 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 72
    10.10.4 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 72
    10.10.5 Mexico Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 72

    11. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 73
    11.1 OVERVIEW 73
    11.2 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
    11.3 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
    11.4 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
    11.5 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
    11.6 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
    11.7 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
    11.8 UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
    11.8.1 UK Epigenetics market Revenue and Forecasts to 2025 (US$ Mn) 78
    11.8.2 UK Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 78
    11.8.3 UK Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 79
    11.8.4 UK Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
    11.8.5 UK Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 79
    11.9 GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
    11.9.1 Germany Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 80
    11.9.2 Germany Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 81
    11.9.3 Germany Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 81
    11.9.4 Germany Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81
    11.9.5 Germany Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 82
    11.10 FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
    11.10.1 France Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 84
    11.10.2 France Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 84
    11.10.3 France Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 85
    11.10.4 France Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 85
    11.10.5 France Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 85

    12. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 86
    12.1 OVERVIEW 86
    12.2 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
    12.3 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
    12.4 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
    12.5 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
    12.6 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
    12.7 ASIA PACIFIC GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
    12.8 CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
    12.8.1 China Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 90
    12.8.2 China Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
    12.8.3 China Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 91
    12.8.4 China Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91
    12.8.5 China Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 91
    12.9 JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
    12.9.1 Japan Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 92
    12.9.2 Japan Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
    12.9.3 Japan Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 93
    12.9.4 Japan Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
    12.9.5 Japan Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94
    12.10 INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95
    12.10.1 India Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 96
    12.10.2 India Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 96
    12.10.3 India Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 97
    12.10.4 India Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 97
    12.10.5 India Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 97

    13. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 98
    13.1 OVERVIEW 98
    13.2 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
    13.3 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
    13.4 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
    13.5 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
    13.6 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
    13.7 MIDDLE EAST AND AFRICA AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
    13.8 UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
    13.8.1 UAE Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 103
    13.8.2 UAE Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
    13.8.3 UAE Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 104
    13.8.4 UAE Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
    13.8.5 UAE Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104
    13.9 SAUDI ARABIA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
    13.10 SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
    13.10.1 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 106
    13.10.2 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 106
    13.10.3 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106
    13.10.4 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 107
    13.11 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107
    13.12 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
    13.12.1 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108
    13.12.2 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 109
    13.12.3 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 109
    13.12.4 South Africa Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 109

    14. SOUTH AND CENTRAL AMERICA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 110
    14.1 OVERVIEW 110
    14.2 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
    14.3 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
    14.4 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
    14.5 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
    14.6 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
    14.7 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
    14.8 BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
    14.8.1 Brazil Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 114
    14.8.2 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 115
    14.8.3 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 115
    14.8.4 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 115
    14.8.5 Brazil Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 116

    15. EPIGENETICS MARKET -INDUSTRY LANDSCAPE 117
    15.1 OVERVIEW 117
    15.2 GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
    15.3 ORGANIC GROWTH STRATEGIES 118
    15.3.1 Overview 118
    15.3.2 Product Launches 118
    15.3.3 Others 119
    15.4 INORGANIC GROWTH STRATEGIES 119
    15.4.1 Overview 119
    15.4.2 Agreements 120
    15.4.3 Acquisition 121

    16. EPIGENETICS MARKET-KEY COMPANY PROFILES 122
    16.1 MERCK KGAA 122
    16.1.1 Key Facts 122
    16.1.2 Business Description 122
    16.1.3 Financial Overview 123
    16.1.4 Product Portfolio 123
    16.1.5 SWOT Analysis 124
    16.1.6 Key Developments 125
    16.2 THERMO FISHER SCIENTIFIC, INC. 126
    16.2.1 Key Facts 126
    16.2.2 Business Description 126
    16.2.3 Financial Information 127
    16.2.4 Product Portfolio 127
    16.2.5 SWOT Analysis 128
    16.2.6 Key Developments 128
    16.3 ABCAM PLC 129
    16.3.1 Key Facts 129
    16.3.2 Business Description 129
    16.3.3 Financial Overview 130
    16.3.4 Product Portfolio 130
    16.3.5 SWOT Analysis 131
    16.3.6 Key Developments 132
    16.4 AGILENT TECHNOLOGIES, INC. 133
    16.4.1 Key Facts 133
    16.4.2 Business Description 133
    16.4.3 Financial Overview 134
    16.4.4 Product Portfolio 134
    16.4.5 SWOT Analysis 135
    16.4.6 Key Developments 135
    16.5 QIAGEN 136
    16.5.1 Key Facts 136
    16.5.2 Business Description 136
    16.5.3 Financial Overview 137
    16.5.4 Product Portfolio 137
    16.5.5 SWOT Analysis 138
    16.5.6 Key Developments 138
    16.6 BIO-RAD LABORATORIES, INC. 139
    16.6.1 Key Facts 139
    16.6.2 Business Description 139
    16.6.3 Financial Information 140
    16.6.4 Product Portfolio 140
    16.6.5 SWOT Analysis 141
    16.6.6 Key Developments 141
    16.7 ACTIVE MOTIF 142
    16.7.1 Key Facts 142
    16.7.2 Business Description 142
    16.7.3 Financial Overview 142
    16.7.4 Product Portfolio 143
    16.7.5 SWOT Analysis 144
    16.7.6 Key Developments 144
    16.8 PERKIN ELMER, INC. 145
    16.8.1 Key Facts 145
    16.8.2 Business Description 145
    16.8.3 Financial Overview 146
    16.8.4 Product Portfolio 146
    16.8.5 SWOT Analysis 147
    16.8.6 Key Developments 147
    16.9 NEW ENGLAND BIOLABS 148
    16.9.1 Key Facts 148
    16.9.2 Business Description 148
    16.9.3 Financial Overview 148
    16.9.4 Product Portfolio 148
    16.9.5 SWOT Analysis 150
    16.9.6 Key Developments 150
    16.10 ILLUMINA, INC. 151
    16.10.1 Key Facts 151
    16.10.2 Business Description 151
    16.10.3 Financial Overview 152
    16.10.4 Product Portfolio 152
    16.10.5 SWOT Analysis 153
    16.10.6 Key Developments 153

    17. APPENDIX 154
    17.1 ABOUT THE INSIGHT PARTNERS 154
    17.2 GLOSSARY OF TERMS 155
    17.3 METHODOLOGY 157
    17.3.1 Coverage 158
    17.3.2 Secondary Research 158
    17.3.3 Primary Research 159

    LIST OF TABLES

    TABLE 1. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
    TABLE 2. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
    TABLE 3. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
    TABLE 4. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
    TABLE 5. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 65
    TABLE 6. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
    TABLE 7. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
    TABLE 8. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 66
    TABLE 9. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
    TABLE 10. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69
    TABLE 11. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
    TABLE 12. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
    TABLE 13. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 71
    TABLE 14. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
    TABLE 15. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
    TABLE 16. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
    TABLE 17. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
    TABLE 18. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
    TABLE 19. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
    TABLE 20. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
    TABLE 21. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78
    TABLE 22. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 79
    TABLE 23. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
    TABLE 24. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 79
    TABLE 25. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
    TABLE 26. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
    TABLE 27. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
    TABLE 28. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 82
    TABLE 29. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84
    TABLE 30. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 85
    TABLE 31. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85
    TABLE 32. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 85
    TABLE 33. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
    TABLE 34. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
    TABLE 35. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
    TABLE 36. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
    TABLE 37. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
    TABLE 38. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91
    TABLE 39. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 91
    TABLE 40. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 91
    TABLE 41. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 93
    TABLE 42. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
    TABLE 43. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
    TABLE 44. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
    TABLE 45. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
    TABLE 46. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 97
    TABLE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
    TABLE 48. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
    TABLE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
    TABLE 50. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
    TABLE 51. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
    TABLE 52. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
    TABLE 53. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
    TABLE 54. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 103
    TABLE 55. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 104
    TABLE 56. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
    TABLE 57. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
    TABLE 58. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
    TABLE 59. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106
    TABLE 60. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 106
    TABLE 61. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
    TABLE 62. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 108
    TABLE 63. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109
    TABLE 64. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109
    TABLE 65. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 109
    TABLE 66. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
    TABLE 67. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
    TABLE 68. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
    TABLE 69. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
    TABLE 70. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 115
    TABLE 71. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 115
    TABLE 72. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 115
    TABLE 73. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 116
    TABLE 74. RECENT PRODUCT LAUNCHES IN THE EPIGENETICS MARKET 118
    TABLE 75. RECENT OTHERS IN THE EPIGENETICS MARKET 119
    TABLE 76. AGREEMENTS INORGANIC DEVELOPMENTS IN THE EPIGENETICS MARKET 120
    TABLE 77. ACQUISITIONS IN THE EPIGENETICS MARKET 121
    TABLE 78. GLOSSARY OF TERMS, EPIGENETICS MARKET 155

    LIST OF FIGURES

    FIGURE 1. ASIA PACIFIC EPIGENETICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 24
    FIGURE 2. GLOBAL EPIGENETICS MARKET BY PRODUCT, MARKET SHARE (%), 2017 25
    FIGURE 3. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 25
    FIGURE 4. GLOBAL EPIGENETICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 26
    FIGURE 5. GLOBAL EPIGENETICS MARKET BY END USER, MARKET SHARE (%), 2017 26
    FIGURE 6. EPIGENETICS MARKET SEGMENTATION 27
    FIGURE 7. EPIGENETICS SEGMENTATION, BY REGION 28
    FIGURE 8. EPIGENETICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS 34
    FIGURE 9. GLOBAL EPIGENETICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025 35
    FIGURE 10. GLOBAL EPIGNETICS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 36
    FIGURE 11. GLOBAL EPIGENETICS MARKET BY PRODUCT, 2017 & 2025 (%) 39
    FIGURE 12. GLOBAL REAGENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
    FIGURE 13. GLOBAL KITS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
    FIGURE 14. GLOBAL ENZYMES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
    FIGURE 15. GLOBAL INSTRUMENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
    FIGURE 16. GLOBAL BIOINFORMATICS TOOLS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
    FIGURE 17. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, 2017 & 2025 (%) 46
    FIGURE 18. GLOBAL HISTONE MODIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
    FIGURE 19. GLOBAL DNA METHYLATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
    FIGURE 20. GLOBAL OTHERS TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
    FIGURE 21. GLOBAL EPIGENETICS MARKET BY APPLICATION, 2017 & 2025 (%) 50
    FIGURE 22. GLOBAL METABOLIC DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
    FIGURE 23. GLOBAL ONCOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
    FIGURE 24. GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
    FIGURE 25. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
    FIGURE 26. GLOBAL EPIGENETICS MARKET BY END USER, 2017 & 2025 (%) 56
    FIGURE 27. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
    FIGURE 28. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
    FIGURE 29. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
    FIGURE 30. NORTH AMERICA EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 60
    FIGURE 31. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
    FIGURE 32. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
    FIGURE 33. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
    FIGURE 34. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
    FIGURE 35. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
    FIGURE 36. EUROPE EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 73
    FIGURE 37. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
    FIGURE 38. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
    FIGURE 39. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
    FIGURE 40. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
    FIGURE 41. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
    FIGURE 42. ASIA PACIFIC EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86
    FIGURE 43. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
    FIGURE 44. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
    FIGURE 45. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
    FIGURE 46. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
    FIGURE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
    FIGURE 48. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 98
    FIGURE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
    FIGURE 50. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
    FIGURE 51. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
    FIGURE 52. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
    FIGURE 53. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 110
    FIGURE 54. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
    FIGURE 55. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
    FIGURE 56. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
    FIGURE 57. GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
    FIGURE 58. ORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 118
    FIGURE 59. INORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 119
    The List of Companies

    1. Merck KGaA
    2. Thermo Fisher Scientific, Inc.
    3. Abcam plc
    4. Agilent Technologies
    5. Active Motif
    6. QIAGEN
    7. Bio-Rad Laboratories, Inc.
    8. PerkinElmer Inc.
    9. New England Biolabs (NEB)
    10. Illumina, Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the epigenetics market.

    • Highlights key business priorities in order to assist companies to realign their business strategies.

    • The key findings and recommendations highlight crucial progressive industry trends in the global epigenetics market, thereby allowing players across the value chain to develop effective long-term strategies.

    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPHE100000971
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount